ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Genscript Biotech Corporation (PK)

Genscript Biotech Corporation (PK) (GNNSF)

1,50
0,00
(0,00%)
Fermé 13 Juillet 10:00PM

Genscript Biotech Corporation (PK) (GNNSF) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
1,50
( - )
Prix Achat
1,50
Prix Vente
1,99
Volume échangé
-
Volume moyen (3 m)
US$ 18 050 761
Volume financier
-
0,00 Fourchette du Jour 0,00
1,30 Plage de 52 semaines 2,42
Cap du marché
Valeur d'Entreprise
3,441B
Clôture Veille
1,50
Ouverture
-
Dernière Transaction
Dernière heure de transaction
VWAP
-
Chiffre d'affairess (LTM)
959,53M
Bénéfice net (LTM)
-532,83M
Actions en circulation
2 188 137 343
Flottant (%)
63,20%
Détention Institutionnelle (%)
17,05%
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-7,26
Ratio Cours/Ventes (P/S)
4,07
Bénéfice par action (BPA)
-0,25
Bêta
0,85

À propos de Genscript Biotech Corporation (PK)

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through Life Science Services and Products;... Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products segments. The Life Science Services and Products segment provide research services and products which are used in fundamental to life-science research and application. The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering. It also offers SurePAGE, a precast gel series; CytoSinct, a Nanobeads product and services; and Benz-Neburase, a genetically engineered endonuclease. In addition, the company provides automated protein and antibody purification system; automated maxi-plasmid purification; automated mini-scale purification for plasmid, protein, and antibody; eBlot and eStain, a protein transfer and staining system; eZwest Lite, an automated western blotting device; CytoSinct, a cell isolation solution; pharmacokinetics and immunogenicity ELISA kits; COVID-19 detection cPass technology kits; and GenBox, a mini electrophoresis tank. It serves antibody drug discovery; gene therapy; vaccine; in vitro diagnostics; gene editing; plant biology; and synthetic biology solutions. The company was founded in 2002 and is headquartered in Wan Chai, Hong Kong. Show more

Secteur
-
Industrie
-
Siège social
Wan Chai, Hong Kong
Fondé
2026
Genscript Biotech Corporation (PK) est coté dans le secteur de la OTC Markets avec le ticker GNNSF. Le dernier cours de clôture d'Genscript Biotech (PK) était de US$1,50. Au cours de la dernière année, les actions de Genscript Biotech (PK) ont été négociées dans une fourchette de prix de US$ 1,30 à US$ 2,42.

Genscript Biotech (PK) compte actuellement 2 188 137 343 actions en circulation. La capitalisation boursière d'Genscript Biotech (PK) est de US$3,28 milliard. Genscript Biotech (PK) a un ratio cours/bénéfice (ratio PE) de -7.26.

GNNSF Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1001.51.51.53001.5CS
4001.51.51.53001.5CS
120.085.63380281691.421.91.423041.66185876CS
26-0.34-18.47826086961.841.91.352941.56178431CS
52-0.17-10.17964071861.672.421.337491.75460354CS
156-0.65-30.23255813952.153.21.05145451.54921602CS
260-3.3-68.754.85.31.0590242.10105376CS

GNNSF - Frequently Asked Questions (FAQ)

What is the current Genscript Biotech Corporation (PK) share price?
The current share price of Genscript Biotech Corporation (PK) is US$ 1,50
How many Genscript Biotech Corporation (PK) shares are in issue?
Genscript Biotech Corporation (PK) has 2 188 137 343 shares in issue
What is the market cap of Genscript Biotech Corporation (PK)?
The market capitalisation of Genscript Biotech Corporation (PK) is USD 3,28B
What is the 1 year trading range for Genscript Biotech Corporation (PK) share price?
Genscript Biotech Corporation (PK) has traded in the range of US$ 1,30 to US$ 2,42 during the past year
What is the PE ratio of Genscript Biotech Corporation (PK)?
The price to earnings ratio of Genscript Biotech Corporation (PK) is -7,26
What is the cash to sales ratio of Genscript Biotech Corporation (PK)?
The cash to sales ratio of Genscript Biotech Corporation (PK) is 4,07
What is the registered address of Genscript Biotech Corporation (PK)?
The registered address for Genscript Biotech Corporation (PK) is Dah Sing Financial Centre, Wan Chai
What is the Genscript Biotech Corporation (PK) website address?
The website address for Genscript Biotech Corporation (PK) is www.genscript.com

GNNSF Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock